key: cord-0850874-ndzfce63
authors: Shuai, Lei; Zhong, Gongxun; Yuan, Quan; Wen, Zhiyuan; Wang, Chong; He, Xijun; Liu, Renqiang; Wang, Jinliang; Zhao, Qinjian; Liu, Yuxiu; Huo, Ningning; Deng, Junhua; Bai, Jingjing; Wu, Hongchao; Guan, Yuntao; Shi, Jianzhong; Tian, Kegong; Xia, Ningshao; Chen, Hualan; Bu, Zhigao
title: Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
date: 2020-12-08
journal: Natl Sci Rev
DOI: 10.1093/nsr/nwaa291
sha: b270b7c4b51ce3d45fcf83c463f43544ec71e3fb
doc_id: 850874
cord_uid: ndzfce63

Minks are raised in many countries and have transmitted severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) to humans. However, the biologic properties of SARS-CoV-2 in minks are largely unknown. Here, we investigated and found that SARS-CoV-2 replicates efficiently in both the upper and lower respiratory tracts, and transmits efficiently in minks via respiratory droplets; pulmonary lesions caused by SARS-CoV-2 in minks are similar to those seen in humans with COVID-19. We further found that a spike protein-based subunit vaccine largely prevented SARS-CoV-2 replication and lung damage caused by SARS-CoV-2 infection in minks. Our study indicates that minks are a useful animal model for evaluating the efficacy of drugs or vaccines against COVID-19 and that vaccination is a potential strategy to prevent minks from transmitting SARS-CoV-2.

The SARS-CoV-2 shares the highest homology at the nucleotide level with the coronavirus RaTG13, which was found in horseshoe bats (Rhinolophus spp.) in Yunnan province, China, in 2013 [9] , implying that the SARS-CoV-2 and RaTG13 may have descended from a similar ancestor.

Although it remains unknown which animal(s) served as intermediate hosts to transfer the virus from its original host to humans, it has been reported that multiple animal species, including ferrets, hamsters, nonhuman primates, cats, dogs, tigers, raccoon dogs, and minks are permissive for SARS-CoV-2 infection or have tested positive in the field [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 ].

Among these susceptible animals, minks are the only species farmed on a large scale in many countries that have transmitted SARS-CoV-2 to humans, suggesting their potential to become a new reservoir of SARS-CoV-2 [20, 24] . However, the biologic properties of SARS-CoV-2 in minks are largely unknown.

Here, we performed a detailed study to understand the replication, pathogenicity, and transmission of SARS-CoV-2 in minks. We also explored the potential of minks to serve as model animals for the development of COVID-19 control measures.

All experiments with infectious SARS-CoV-2 were performed in the biosafety level 4 and animal biosafety level 4 facilities in the Harbin Veterinary Research Institute (HVRI) of the Chinese Academy of Agricultural Sciences (CAAS), which were approved for such use by the Ministry of Agriculture and Rural Affairs of China. Details of the biosafety and biosecurity measures taken were described previously [14] . The protocols for animal study and animal welfare were reviewed and approved by the Committee on the Ethics of Animal Experiments of the HVRI of CAAS (approval number 2020-05-01JiPi).

To investigate the replication and tissue tropism of SARS-CoV-2 in minks, three 13-month-old minks were inoculated intranasally (i.n.) with 5×10 6 plaque-forming units (PFU) in 1ml of the SARS-CoV-2 HRB25 strain, which was isolated from a patient in Harbin in February, 2020 [25] .

Nasal washes, concha swabs, and rectal swabs were collected on days 2 and 4 post-inoculation (p.i.)

for viral RNA and infectious virus detection. On day 4 p.i., the minks were euthanized and their nasal turbinates, soft palates, tonsils, tracheas, lungs, hearts, submaxillary lymph nodes, kidneys, spleens, livers, small intestines, and brains were collected for viral RNA and infectious virus detection.

Viral RNA was detected in the nasal washes of all three animals on days 2 and 4 p.i., and also from the ear swabs and rectal swabs of two animals on day 2 p.i. (Fig. 1A) . Infectious virus was detected in the nasal washes of all three animals on days 2 and 4 p.i., but not from the concha swabs or rectal swabs of any animals at any time points (Fig. 1B) . Viral RNA was detected in the nasal turbinates, soft palates, tonsils, all lung lobes, and submaxillary lymph nodes of all three minks, in the trachea of two minks, and in the ileum of one mink, but was not detected in any other organs of any animal tested (Fig. 1C) . Infections virus was detected in most of the viral RNA-positive samples Importantly, most of these pathologic changes have been observed in human COVID-19 patients [28, 29, 30] , as summarized in table 1, suggesting that SARS-CoV-2 causes similar damage to the respiratory systems of minks and humans.

To investigate the ability of SARS-CoV-2 to transmit among minks via respiratory drops, three animals were inoculated i.n. with 5×10 6 PFU of HRB25 and each animal was placed in a separate cage within an isolator. Twenty-four hours later, three naive minks were placed in each cage adjacent to the ones that held the virus-inoculated mink without direct contact. Nasal washes, and rectal and concha swabs were collected every other day from days 2 to 18 p.i. from the inoculated animals [and from days 1 to 17 post-exposure (p.e.) from the exposed animals] for viral RNA detection and virus titration. Body weights of all six animals were recorded every other day. In the three virus-inoculated minks, viral RNA was detected in the nasal washes of all three animals on days 2, 4, 6, and 8 p.i., and in the nasal washes of two animals and one animal on days 10 and 12 p.i., respectively, but not from any animals on days 14, 16, and 18 p.i. (Fig. 3A) . Viral RNA was also detected in the concha swab of one mink on days 4 and 6 p.i. and in the rectal swab of another mink on day 8 p.i., (fig. S2A ). Among the exposed minks, viral RNA was started to be detected in the nasal washes of one, two, and all three animals on days 3, 5 and 9 p.e., respectively (Fig. 3A) . Viral RNA was also detected from the concha swab and rectal swab of one mink on day 11 p.i. and day 13 p.i., respectively (fig. S2, A and

. Infectious virus was detected in the nasal washes of the infected minks from days 2 to 8 p.i., and in the nasal washes of the exposed animals from days 5 to 11 p.e. (Fig. 3B) , but was not detected in the concha swabs or rectal swabs of any of the minks ( fig. S2, B and D) . The inoculated minks experienced 10%-20% body weight loss during the 18-day observation period (Fig. 3C) ; one virus-inoculated mink experienced watery nasal discharge. The exposed minks lost about 5% of their body weight (Fig. 3D) . All of the inoculated and exposed minks seroconverted on day 18 p.i. (Fig. 3 , E and F). These data indicate that SARS-CoV-2 easily transmits among minks via respiratory droplets.

A spike protein-based subunit vaccine protects minks against SARS-CoV-2

The above studies indicate that minks are most similar to humans in terms of replication, Nasal washes of the three remaining minks in each group were collected for viral RNA detection and infectious virus titration. Viral RNA was detected in the nasal washes of the control minks on days 2, 4, 6, 8, 10, and 12 p.c., but was only detected in the nasal washes of the vaccinated minks on days 2, 4, and 6 p.c. with significantly low levels (Fig. 4C) . Infectious virus was detected in the nasal washes of the control minks on days 2, 4, 6, and 8 p.c., but was only detected in the nasal wash of one vaccinated mink on day 2 p.c. (Fig. 4D) .These studies show that the spike protein-based subunit ; however, in the present study, we found that virus-inoculated minks lost 10%-20% of their body weight at around day 8 p.i.,

and exposed minks lost about 5% of their body weight, but none of the virus-inoculated or -exposed minks died. The exposed animals lost less body weight than the virus-inoculated animals, largely because the initial dose received by the exposed animals was much lower than that received by the inoculated animals, although the titer of the virus in the exposed animals reached a peak level similar to that of the inoculated animals. These findings suggest that pregnant minks may be more vulnerable to SARS-CoV-2 infection than non-pregnant ones. Given that minks are highly susceptible to SARS-CoV-2 and could be easily infected by this widely spreading virus, surveillance and active control measures in minks should be implemented to prevent minks from becoming reservoirs of SARS-CoV-2.

Animal models are needed for the evaluation of vaccines and antiviral drugs for COVID-19.

Human angiotensin-converting enzyme 2 (hACE-2) receptor transgenic mice have been generated and proved to be susceptible to SARS-CoV-2 infection, resulting in a range of clinical signs with mild to fatal disease depending on the transgene [31, 32, 33, 34] . SARS-CoV-2 adaptation to mice has also

been attempted through either serial passaging or reverse genetics [35, 36, 37] . Non-human primates, including rhesus macaques, African green monkeys, and marmosets, have been shown to be susceptible to SARS-CoV-2 infection [38, 39, 40, 41] . Ferrets have also been shown to be susceptible to SARS-CoV-2 infection resulting in mild disease with shedding from the upper respiratory tract [14, 17, 42, 43] .

Both minks and ferrets are mustelid and are highly susceptible to SARS-CoV-2; however, the replication patterns of SARS-CoV-2 in ferrets and minks are different. Studies shown that the host factors, such as ACE2 [9, 44, 45, 46] and neuropilin-1 [47, 48] , play important roles in the SARS-CoV-2 replication, it remains to be investigated if ferrets and minks have different expression levels of these critical host factors in their organs. SARS-CoV-2 efficiently replicates in the upper respiratory tract of ferrets, but its replication in the lungs of ferrets is undetectable [14] . Therefore, the ferret model can only be used to assess the efficacy of vaccines or antivirals in preventing or reducing virus replication in the upper respiratory tract; it cannot be used to evaluate whether they reduce or eliminate lung lesions. SARS-CoV-2 replicates in the upper and lower respiratory tracts of minks and causes lung lesions highly similar to those seen in human COVID-19 patients [28, 30] . Accordingly, using minks as model animals will enable us to more precisely evaluate the efficacy of antiviral drugs or vaccines for COVID-19.

Minks are raised on a large scale in many countries and are at high risk of SARS-CoV-2 infection.

In fact, SARS-CoV-2 infection of minks has been reported in several countries in Europe and the Americas, and millions of minks have been culled to control the spread of the virus [24] . In the present study, we found that a spike protein-based subunit vaccine largely prevented SARS-CoV-2 replication and protected minks from SARS-CoV-2-induced lung damage. Our previous studies with H7N9

influenza viruses have showed that vaccinated animals could be perfectly protected from exposure to virus infected animals, even though the vaccine cannot provide complete protection when the animals were challenged by direct infection [49, 50] . Given that the vaccine provided sound protection to high dose of SARS-CoV-2 challenge, it is reasonable to speculate that the vaccinated animals would be protected from infection of natural exposure. Vaccination may, therefore, be an option for preventing SARS-CoV-2 infection of minks.

The detailed descriptions of materials and methods are available as Supporting information at NSR online.

All data are available in the manuscript or the supplementary materials. 

Coronavirus as a possible cause of severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

A Novel Coronavirus from Patients with Pneumonia in China

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses

World Health Organization. Coronavirus disease (COVID-2019) situation report for 11

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Complete Genome Sequence of SARS-CoV-2 in a Tiger from a

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Infection of dogs with SARS-CoV-2

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Age-related rhesus macaque models of COVID-19

Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

Coronavirus rips through Dutch mink farms, triggering culls

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Olfactory Dysfunction in Coronavirus Disease

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Generation of a Broadly Useful Model for COVID-19

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection

A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals

A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals

Intra-and inter-alveolar hemorrhages (cloverleaf) and serous-fibrin exudation (asterisk). (F) Multinucleated syncytial cell in alveolar space (arrow). (G) Intra-and inter-alveolar foamy macrophage proliferation (arrow). (H) Severe lymphoplasmacytic perivasculitis and vasculitis (dotted line), and fibrin formation (asterisk) in a blood vessel

Degeneration of bronchiolar epithelium (arrow). (K) Peribronchiolar inflammatory infiltrate (dotted line). (L) Degeneration of bronchial gland epithelium. (M, N) Viral antigen-positive cells in the lung (arrow) and in (O) bronchi epithelium (arrow). (P) Marked proliferation of macrophages, monocytes, and neutrophils

Deposition of intra-and inter-alveolar collagen confirmed by Masson trichrome (blue) staining. (R) Embolus of mucous-fibrin mixture in bronchial lumen confirmed by MSB staining

We thank S. Watson for editing the manuscript.

This work was supported by the National Key R&D Program of China (2018YFC1200601,